Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Idexx Laboratories, Inc.
Swot
Idexx Laboratories, Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Idexx Laboratories, Inc. has 26 Strengths, 6 Weaknesses, 1 Opportunities and 3 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(26)
Weakness
(6)
Opportunity
(1)
Threats
(3)
Others
(0)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Stars (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
High Normalized Momentum Score
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Stocks whose current price is 20% higher than week low, and more than previous close
Weekly Strategy: High Momentum Score Stocks (subscription)
Relative Outperformance versus Industry over 10 Years
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Near 52 Week High
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Increasing profits every quarter for the past 2 quarters
Top Gainers
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
PE higher than Industry PE
PEG greater than Industry PEG
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Declining Net Cash Flow : Companies not able to generate net cash
Institutions increasing their shareholding
Stocks rising sharply on very low month volumes
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter